Table 1.
Participants’ description. Summary of participants description and detailed scale values. S: sex, A: age in years, R: right, L: left, I: ischemic, H: hemorrhagic, TACS: total anterior circulation stroke, PACS: partial anterior circulation stroke, POCS: posterior circulation syndrome, LACS: lacunar stroke.
| ID | S | A | Diagnostic 1 | Comorbidities | Drugs | BBS 2 | MBT 2 | BI 2 |
|---|---|---|---|---|---|---|---|---|
| TELE_PT 750352 |
F | 62 | POCS/R/I/8 | Arterial Hypertension, Diabetes Mellitus type 2, High cholesterol |
Losartan, Metformin, Atorvastatin, Aspirin | 33/44 | 9/15 | 60/95 |
| TELE_PT 981,283 |
M | 46 | PACS/R/H/7 | Arterial Hypertension, Diabetes Mellitus type 2, Smoking, Dyslipidemia | Metformin, Atorvastatin | 35/47 | 9/20 | 65/85 |
| TELE_PT 798,056 |
F | 62 | TACS/L/H/6 | Gastric Bypass (2015) | Sertraline | 30/42 | 8/18 | 60/75 |
| TELE_PT 361,739 |
M | 63 | PACS/L/I/7 | Arterial Hypertension | Losartan | 33/50 | 10/22 | 70/85 |
| TELE_PT 194,267 |
F | 54 | LACI/L/I/8 | Arterial Hypertension, Diabetes Mellitus type 2, Dyslipidemia | Losartan, Metformin, Insulin, Sertraline, Aspirin | 36/46 | 10/16 | 70/85 |
| TELE_PT 210,586 |
M | 55 | POCS/L/I/7 | Arterial Hypertension, Diabetes Mellitus type 2 | Aspirin, Losartan, Metformin | 43/49 | 16/21 | 65/70 |
| CONTROL 955,948 | M | 62 | PACS/L/I/7 | Dyslipidemia | Aspirin, Atorvastatin | 46/51 | 19/24 | 95/95 |
| CONTROL 328,977 | M | 79 | LACS/R/I/7 | Dyslipidemia, Arterial Hypertension | Atorvastatin, Carvedilol | 41/47 | 9/15 | 60/65 |
| CONTROL 254,683 | M | 61 | PACS/R/I/6 | No | Aspirin | 20/34 | 4/5 | 25/40 |
| CONTROL 254,688 | F | 69 | PACS/R/I/6 | Dyslipidemia, Arterial Hypertension | Losartan | 36/39 | 9/16 | 65/60 |
| TELE PT PRE/POST Average | 35.00/46.33 | 10.33/18.67 | 65.00/ 82.50 |
|||||
| CONTROL PRE/POST Average | 35.75/42.75 | 10.25/ 15.00 |
61.25/ 65.00 |
|||||
1 Bamborf [17]/side/etiology/weeks after stroke onset; 2 PRE/POST.